A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Phase 4CompletedNCT00157872

Merck Sharp & Dohme LLC150 enrolled

Overview

A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

150

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Chinese males or females at least 18 years of age with rheumatoid arthritis

Tender joint count

swollen joint count

patient's global assessment of disease activity

investigator's global assessment of disease activity

Patient pain assessment

patient's global assessment of response to therapy

investigator's global assessment of response to therapy

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.